
From the fear of diabetic ketoacidosis to the real cost of monitoring, Ellen Behrend, VMD, MS, PhD, DACVIM (SAIM), makes the case that SGLT2 inhibitors are safer and easier to use in cats with diabetes than many practitioners assume, and explains who the right candidate is.








































